Merger And CollaborationThe proposed merger of topical ophthalmic platforms could present the next constructive chapter for Optejet and broader development.
Product DevelopmentCollaborations in dry eye disease development are seen as upside, with the user-filled Optejet potentially defining the most realistic shot for near-term progress.
Technology And InnovationEyenovia’s Optejet ophthalmic spray device is already FDA approved for Mydcombi, which is used for induced pupil dilation for eye exams and related surgery.